Non-axillary breast cancer recurrences after sentinel node biopsy

Rijk, Maartje C. van; Nieweg, Omgo E.; Olmos, Renato A. Valdés; Rutgers, Emiel J.; Hoefnagel, Cornelis A.; Kroon, Bin B. R.

doi:10.1002/jso.20407

Cited by 9 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such recurrences are rare and most commonly followed by distant metastasis (11 of 14 patients in the present study). It could be debated whether extra‐axillary nodal recurrence should be viewed as the consequence of a false‐negative SNB finding or as a secondary aberrant primary drainage pattern; however, as this is an rare event, an answer is difficult to obtain.…”

Section: Discussionmentioning

confidence: 99%

Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study

Boniface

Frisell

Bergkvist

et al. 2017

British Journal of Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study

Boniface

Frisell

Bergkvist

et al. 2017

British Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…In this study, all 3 IMLN recurrent patients (0.6%) underwent chemo-radiation therapy. van Rijk et al [16] explained that the failure of extra-axillary SLN biopsy is the cause of extra-axillary nodal recurrence of breast cancer. These authors also found that all IMLN metastasis developed 24, 46, and 63 months after surgery.…”

Section: Discussionmentioning

confidence: 99%

Long-Term Outcome of Internal Mammary Lymph Node Detected by Lymphoscintigraphy in Early Breast Cancer

et al. 2012

View full text Add to dashboard Cite

PurposeInternal mammary lymph node (IMLN) metastasis is an important prognostic indicator in breast cancer. However, the necessity of internal mammary sentinel lymph node biopsy for accurate staging, for choosing adjuvant treatment, and as a prognostic indicator, has remained controversial.MethodsFrom January 2001 to December 2006, 525 female breast cancer patients underwent radical surgery after preoperative lymphatic scintigraphy. We retrospectively analyzed the follow-up results, recurrences, and deaths of all patients.ResultsThere was no significant difference in the clinicopathological characteristics between the axilla and the IMLN groups. The median follow-up period was 118.8 months (range, 7-122 months) in the axilla group and 107.7 months (range, 14-108 months) in the IMLN group. During the median follow-up period, the breast cancer-related death rate in the axilla group was 3.6%, which was not significantly different from that of the IMLN group (1.3%) (p=0.484). The five-year survival rates did not differ between the two groups (p=0.306). The overall recurrence rate and the locoregional recurrence rate also did not differ between the two groups (p=0.835 and p=0.582, respectively). The recurrence rate of IMLN (both ipsilateral and contralateral) metastasis was very low, accounting for 0.5% in the axilla group and 1.3% in the IMLN group (p=0.416).ConclusionThe long-term follow-up results showed that there was no significant difference in both overall outcome and regional recurrence between the two groups. Therefore, the requirement for identification of nodal basins outside the axilla or IMLN sentinel biopsy should be reconsidered.

show abstract

Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hr after tracer injection in sentinel lymph node biopsy in breast cancer patients

Doting

Stiekema

Vries

et al. 2006

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

Non-axillary breast cancer recurrences after sentinel node biopsy

Cited by 9 publications

References 17 publications

Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study

Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study

Long-Term Outcome of Internal Mammary Lymph Node Detected by Lymphoscintigraphy in Early Breast Cancer

Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hr after tracer injection in sentinel lymph node biopsy in breast cancer patients

Contact Info

Product

Resources

About